Wednesday, September 23, 2020

Zydus Cadila gets tentative USFDA nod to market anti-cancer drug

Zydus Cadila gets tentative USFDA nod to market anti-cancer drug Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Palbociclib Capsules in the strengths of 75 mg, 100 mg, and 125 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3mQ33KH
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Market moves driven more by psychology than fundamentals: Samir Arora

Indian stock markets are caught between global worries and strong domestic company profits. Foreign investor activity, oil price swings, and...